Bayesian network-based survival prediction model for patients having undergone post-transjugular intrahepatic portosystemic shunt for portal hypertension

Figure 6 Bayesian inference for patients aged ≥ 60 years with hypertension, alkaline phosphatase > 135 U/L, aspartate aminotransferase > 40 U/L, and prealbumin < 150 mg/L. ALP: Alkaline phosphatase; AST: Aspartate aminotransferase; MELD: Model for end-stage liver disease; TBIL: Total bilirubin; TIPS: Transjugular intrahepatic portosystemic shunt; PA: Prealbumin; PVP: Portal vein pressures.